Using HIV Risk Assessment Tool to Promote HIV Testing Among Men Who Have Sex With Men

NCT ID: NCT03320239

Last Updated: 2017-10-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

4500 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-10-12

Study Completion Date

2018-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of the study is to evaluate the effectiveness of a HIV risk assessment tool to promote HIV testing and to reduce high risk sexual behaviors among men who have sex with men (MSM). It hypothesizes that the social media-based HIV risk assessment tool can increase 20% HIV testing proportion during the six months follow-up period.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

HIV/AIDS HIV Infections Social Media

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

HIV risk assessment HIV testing unprotected anal intercourse Social medica

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

the online-RASSL intervention group

HIV risk assessment and tailored suggestions, free HIV testing link

Group Type EXPERIMENTAL

HIV risk assessment and tailored suggestions

Intervention Type BEHAVIORAL

The intervention contains: HIV risk investigation, tailored suggestions and free HIV testing link

intervention group 2

HIV risk behavior investigation and routine education

Group Type EXPERIMENTAL

HIV risk behavior assessment

Intervention Type BEHAVIORAL

It only contains HIV risk behavior assessment and routine education

the control group

The placebo control: HIV/AIDS knowledge assessment, routine education

Group Type PLACEBO_COMPARATOR

placebo control

Intervention Type BEHAVIORAL

It only contains HIV/AIDS knowledge assessment and routine education

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

HIV risk assessment and tailored suggestions

The intervention contains: HIV risk investigation, tailored suggestions and free HIV testing link

Intervention Type BEHAVIORAL

HIV risk behavior assessment

It only contains HIV risk behavior assessment and routine education

Intervention Type BEHAVIORAL

placebo control

It only contains HIV/AIDS knowledge assessment and routine education

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male at birth.
* Having had homo-sexual behaviors (anal/oral) in the past 6 months before enrollment.
* An age of 18 years or older.
* Living in Beijing, China.
* Self-reporting HIV negative or unknown.
* Willingly participating into the baseline survey and the six months follow ups.
* Agreeing not to share the research link to others.
* Owning a mobile phone and having had downloaded the social networking Application Blued before enrollment.

Exclusion Criteria

* Not accepting blood sampling within the study period.
* Reporting injecting drugs use in the past six months before enrollment.
* Being currently involved in other HIV behavioral interventions for MSM.
* Having a specific plan to leave from Beijing in the next 6 months.
* Self-reporting female.
* Other reasons the investigators deem make participation either detrimental to the participants or the study.
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Center for AIDS/STD Control and Prevention, China CDC

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Wu Z You, PhD

Role: STUDY_DIRECTOR

NATIONAL CENTER FOR HIV/STD CONTROL AND PREVENTION

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

national center for AIDS control and prevention

Beijing, Beijing Municipality, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Wu Z You, PhD

Role: CONTACT

Phone: 010-58900946

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Zunyou Wu, PHD

Role: primary

References

Explore related publications, articles, or registry entries linked to this study.

Luo Q, Wu Z, Mi G, Xu J, Scott SR. Using HIV Risk Self-Assessment Tools to Increase HIV Testing in Men Who Have Sex With Men in Beijing, China: App-Based Randomized Controlled Trial. J Med Internet Res. 2023 Sep 1;25:e45262. doi: 10.2196/45262.

Reference Type DERIVED
PMID: 37656500 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

risk assessment

Identifier Type: -

Identifier Source: org_study_id